FDA approves GSK RSV vaccine By: MarketWatch May 03, 2023 at 13:56 PM EDT GSK's Arexvy, the first RSV vaccine approved for use in the U.S., gets the green light for older adults. Read More >> Related Stocks: GSK plc American Depositary Shares (Each representing two Ordinary Shares)
